Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18990504 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: estramustine phosphate sodium;   Drug: etoposide;   Drug: flutamide;   Drug: paclitaxel;   Drug: Luteinizing hormone releasing hormone [LHRH] agonist;   Radiation: Radiation therapy;   Drug: warfarin

Indicates status has not been verified in more than two years